Shanghai Hile Bio-Technology Co (SHSE:603718) Additional Paid-In Capital : ¥52.5 Mil(As of Jun. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Shanghai Hile Bio-Technology Co Additional Paid-In Capital?

Shanghai Hile Bio-Technology Co's quarterly additional paid-in capital declined from Dec. 2023 (¥52.5 Mil) to Mar. 2024 (¥0.0 Mil) but then increased from Mar. 2024 (¥0.0 Mil) to Jun. 2024 (¥52.5 Mil).

Shanghai Hile Bio-Technology Co's annual additional paid-in capital stayed the same from Dec. 2021 (¥0.0 Mil) to Dec. 2022 (¥0.0 Mil) but then increased from Dec. 2022 (¥0.0 Mil) to Dec. 2023 (¥52.5 Mil).

Shanghai Hile Bio-Technology Co Additional Paid-In Capital Historical Data

The historical data trend for Shanghai Hile Bio-Technology Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Hile Bio-Technology Co Additional Paid-In Capital Chart

Shanghai Hile Bio-Technology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

36.76

52.54

Shanghai Hile Bio-Technology Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Additional Paid-In Capital	Get a 7-Day Free Trial															-	-	52.54	-	52.54

Shanghai Hile Bio-Technology Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Shanghai Hile Bio-Technology Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Shanghai Hile Bio-Technology Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Hile Bio-Technology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Hile Bio-Technology Co Ltd (SHSE:603718) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

Shanghai Jinhai Road 6720, Shanghai, CHN, 201403

Website

http://www.hile-bio.com

Shanghai Hile Bio-Technology Co Ltd is a veterinary biological product manufacturer integrating research and development, production, sales, and service. The company has over 40 categories of poultry, livestock, and pets. The company provides services for the prevention of livestock diseases, improving the health of livestock and poultry, and improving the production efficiency of farmers, and is able to provide comprehensive solutions and an authoritative veterinary expert service system.

Executives

Zhang Lu	Director
Liu Han Ping	Directors, senior managers
Zhou Yu Sheng	Supervisors
Zhang Hai Ming	Director
Sun Guo Bao	Supervisors
Zhang Yue	Director
Su Bin	Director
Wu Ling Yue	senior management

Shanghai Hile Bio-Technology Co Headlines

No Headlines